Evidence map›Paper›PMID 33857419›Full record

ArticleCell host & microbe2021

Il4ra-independent vaginal eosinophil accumulation following helminth infection exacerbates epithelial ulcerative pathology of HSV-2 infection.

Alisha Chetty, Matthew G Darby, Pia M Vornewald, Mara Martín-Alonso, Anna Filz, Manuel Ritter, Henry J McSorley, Lindi Masson, Katherine Smith, Frank Brombacher and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Cell host & microbe, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 35 citations in OpenAlex.

  1. Tissue adaptation of eosinophils.Journal of leukocyte biology · 2026
    Review
  2. Article
  3. Review
  4. Impact ofTropical medicine and infectious disease · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Eosinophils promote CD8Signal transduction and targeted therapy · 2024
    Article
  17. Review
  18. Review
  19. Article
  20. Induction of Siglec-FFrontiers in immunology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 12 institutions in 7 countries.

Alisha ChettyWellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine (IDM), Department of Pathology, Division of Immunology, Faculty of Health Science, University of Cape Town, Cape Town 7925, South Africa.
Matthew G DarbyWellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine (IDM), Department of Pathology, Division of Immunology, Faculty of Health Science, University of Cape Town, Cape Town 7925, South Africa.
Pia M VornewaldCEMIR - Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, NTNU - Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Mara Martín-AlonsoCEMIR - Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, NTNU - Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Anna FilzInstitute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), 53105 Bonn, Germany.
Manuel RitterInstitute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), 53105 Bonn, Germany.
Henry J McSorleyDivision of Cell Signaling and Immunology, School of Life Sciences, University of Dundee, Wellcome Trust Building, Dow St, Dundee DD1 5EH, UK.
Lindi MassonInstitute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town 7925, South Africa; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa; Life Sciences Discipline, Burnet Institute, Department of Infectious Diseases, Monash University, Melbourne, VIC 3004, Australia.
Katherine SmithInstitute of Infection and Immunity, University of Cardiff, Cardiff CF14 3XN, UK.
Frank BrombacherWellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine (IDM), Department of Pathology, Division of Immunology, Faculty of Health Science, University of Cape Town, Cape Town 7925, South Africa; International Centre for Genetic Engineering and Biotechnology, Cape Town 7925, South Africa.
Matthew K O'SheaInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Adam F CunninghamInstitute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Bernhard RyffelLaboratory of Experimental and Molecular Immunology and Neurogenetics (INEM), UMR 7355 CNRS-University of Orléans, 45000 Orléans, France.
Menno J OudhoffCEMIR - Centre of Molecular Inflammation Research, Department of Clinical and Molecular Medicine, NTNU - Norwegian University of Science and Technology, 7491 Trondheim, Norway.
Benjamin G DewalsFundamental and Applied Research in Animals and Health (FARAH), Immunology-Vaccinology, Faculty of Veterinary Medicine (B43b), University of Liège, Liège, Belgium.
Laura E LaylandInstitute for Medical Microbiology, Immunology and Parasitology (IMMIP), University Hospital Bonn (UKB), 53105 Bonn, Germany; German Centre for Infection Research (DZIF), partner site, Bonn-Cologne, Bonn, Germany. Electronic address: laura.layland@microbiology-bonn.de.
William G C HorsnellWellcome Centre for Infectious Diseases Research in Africa (CIDRI-Africa), Institute of Infectious Disease and Molecular Medicine (IDM), Department of Pathology, Division of Immunology, Faculty of Health Science, University of Cape Town, Cape Town 7925, South Africa; Laboratory of Experimental and Molecular Immunology and Neurogenetics (INEM), UMR 7355 CNRS-University of Orléans, 45000 Orléans, France; Institute of Microbiology and Infection, University of Birmingham, Birmingham, UK. Electronic address: wghorsnell@gmail.com.
Norwegian University of Science and Technology · NOUniversity Hospital Bonn · DEUniversity of Birmingham · GBBurnet Institute · AUCardiff University · GBCentre National de la Recherche Scientifique · FRImmunologie et Neurogénétique Expérimentales et Moléculaires · FRInternational Centre for Genetic Engineering and Biotechnology · ZAUniversity of Cape Town · ZAUniversity of Liège · BEWellcome Centre for Infectious Diseases Research in Africa · ZAWellcome Trust · GB

Funding

Medical Research Council MR/S000593/2Wellcome Trust
6 · The paper itself

Abstract

How helminths influence the pathogenesis of sexually transmitted viral infections is not comprehensively understood. Here, we show that an acute helminth infection (Nippostrongylus brasiliensis [Nb]) induced a type 2 immune profile in the female genital tract (FGT). This leads to heightened epithelial ulceration and pathology in subsequent herpes simplex virus (HSV)-2 infection. This was IL-5-dependent but IL-4 receptor alpha (Il4ra) independent, associated with increased FGT eosinophils, raised vaginal IL-33, and enhanced epithelial necrosis. Vaginal eosinophil accumulation was promoted by IL-33 induction following targeted vaginal epithelium damage from a papain challenge. Inhibition of IL-33 protected against Nb-exacerbated HSV-2 pathology. Eosinophil depletion reduced IL-33 release and HSV-2 ulceration in Nb-infected mice. These findings demonstrate that Nb-initiated FGT eosinophil recruitment promotes an eosinophil, IL-33, and IL-5 inflammatory circuit that enhances vaginal epithelial necrosis and pathology following HSV-2 infection. These findings identify a mechanistic framework as to how helminth infections can exacerbate viral-induced vaginal pathology.

Indexed as

AnimalsEosinophilsFemaleHelminthiasisHelminthsHerpes SimplexHerpesvirus 2, HumanImmunityInterleukin-33Interleukin-4 Receptor alpha SubunitInterleukin-5NecrosisNippostrongylusReceptors, Cell SurfaceVaginaVaginal DiseasesIl4ra protein, mouseInterleukin-33Interleukin-4 Receptor alpha SubunitInterleukin-5Receptors, Cell Surfaceeosinophilsepithelial ulcerationhelminthsHSV-2IL-33IL-5Nippostrongylus brasiliensissystemic immunityvagina

Identifiers

PMID33857419
PMCPMC8062792
OpenAlexW3155964721

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.